Norethisterone transdermal - AllerganAlternative Names: NEA TDS; Norethindrone acetate patch; Norethindrone transdermal - Allergan; Progestin-only patch
Latest Information Update: 16 Feb 2016
At a glance
- Originator Watson Pharmaceuticals
- Developer Allergan
- Class Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Contraception